Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension

Ítems similars

• The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study
  per: Sato, Takahiro, et al.
  Publicat: (2017)
• Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension
  per: Hassoun, Paul M., et al.
  Publicat: (2015)
• Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction
  per: Bourji, Khalil I., et al.
  Publicat: (2017)
• Hemodynamic effects of ambrisentan-tadalafil combination therapy on progressive portopulmonary hypertension
  per: Yamashita, Yu, et al.
  Publicat: (2014)
• The Minimal Important Difference in Borg Dyspnea Score in Pulmonary Arterial Hypertension
  per: Khair, Rubina M., et al.
  Publicat: (2016)